跳至主要内容
临床试验/NCT00308295
NCT00308295已完成不适用

A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients

Indiana University School of Medicine4 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2006年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
4
主要终点
To determine whether AHA-recommended fish oil therapy beneficially affects the pro-inflammatory/anti-inflammatory blood fatty acid balance

研究概览

简要总结

The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 82 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Pregnant individuals
  • Fish oil or omega-3 supplementation in past 6 months
  • Fish, corn, soybean, gelatin, or vanilla allergies
  • Currently enrolled in a dietary or investigational drug study
  • Life expectancy < 3 months
  • Ongoing active illness requiring hospitalization
  • Malabsorption syndromes
  • Chronic heparin or coumadin anticoagulation (??)
  • Active bleeding issues

结局指标

主要结局

To determine whether AHA-recommended fish oil therapy beneficially affects the pro-inflammatory/anti-inflammatory blood fatty acid balance

次要结局

  • To test the safety and tolerability of fish oil therapy in hemodialysis patients
  • To measure the effects of fish oil treatment on cardiovascular and inflammatory risk factors

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验